ADVANCING ACCESS FOR ALL Trademark

Trademark Overview

On Thursday, March 1, 2018, a trademark application was filed for ADVANCING ACCESS FOR ALL with the United States Patent and Trademark Office. The USPTO has given the ADVANCING ACCESS FOR ALL trademark a serial number of 87816040. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 25, 2021. This trademark is owned by JAVARA, INC.. The ADVANCING ACCESS FOR ALL trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business services provided to the pharmaceutical and healthcare industries, namely, managing clinical trials
advancing access for all

General Information

Serial Number87816040
Word MarkADVANCING ACCESS FOR ALL
Filing DateThursday, March 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Goods and ServicesBusiness services provided to the pharmaceutical and healthcare industries, namely, managing clinical trials

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 8, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJAVARA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWINSTON-SALEM, NC 27101
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressWinston-Salem, NC 27101
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressWinston-Salem, NC 27101

Trademark Events

Event DateEvent Description
Monday, October 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 9, 2021EXTENSION 5 GRANTED
Friday, March 5, 2021EXTENSION 5 FILED
Friday, March 5, 2021TEAS EXTENSION RECEIVED
Saturday, September 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2020EXTENSION 4 GRANTED
Thursday, September 17, 2020EXTENSION 4 FILED
Thursday, September 17, 2020TEAS EXTENSION RECEIVED
Wednesday, March 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2020EXTENSION 3 GRANTED
Monday, March 16, 2020EXTENSION 3 FILED
Monday, March 16, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 13, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2019EXTENSION 2 GRANTED
Wednesday, September 18, 2019EXTENSION 2 FILED
Wednesday, September 18, 2019TEAS EXTENSION RECEIVED
Wednesday, July 31, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2019EXTENSION 1 GRANTED
Monday, March 18, 2019EXTENSION 1 FILED
Monday, March 18, 2019TEAS EXTENSION RECEIVED
Friday, February 1, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2018ASSIGNED TO EXAMINER
Thursday, March 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

access advancing namely managing clinical trials industries healthcare services provided pharmaceutical business